About PathoscribeAI
We are a team of AI experts and scientists applying advanced computational methods to solve critical challenges in pharmaceutical discovery and development.
Our Story
Founded in February 2025, PathoscribeAI was started by a group of AI specialists with a shared, strong interest in healthcare. Our founding principle was simple: advanced computation could dramatically improve and accelerate the long, costly process of drug development.
Our team combines deep expertise in machine learning, computational biology, and software engineering to build our intelligent platform. This system is designed to analyze complex datasets—from molecular structures to clinical trial results—to identify promising therapeutic candidates and novel biological targets.
We are driven by the challenge of applying technology to solve complex medical problems, both by finding new uses for existing medicines and by discovering new molecules for the treatments of the future.
Our Mission
Our core mission is to accelerate therapeutic discovery. We utilize advanced AI for both de novo drug design and high-throughput screening of repurposed compounds, aiming to shorten the R&D lifecycle and enhance preclinical success rates.
Accelerate R&D Timelines
Reduce Development Costs
Improve Patient Outcomes
By applying in-silico analysis to complex biological data, we help pharmaceutical partners optimize their development pipelines and unlock the full potential of their molecular data assets.
Our Vision
We envision a future where AI-driven pharmacology is the standard, fostering an ecosystem of rapid innovation that expands the global therapeutic arsenal and streamlines the path from lab to clinic.
Lead in AI-Pharma Innovation
Address Unmet Medical Needs
Transform Healthcare Delivery
Our goal is to become the global leader in AI-powered drug discovery, playing a pivotal role in tackling critical diseases and fundamentally improving health outcomes for patients worldwide.
Our Journey
Key milestones that have shaped our progress and defined our path forward.
February 2025
PathoscribeAI Founded
A team of AI specialists came together to build agentic systems for drug repurposing and discovery.
2026
Scaling Our Repurposing Platform
Expanding pilot engagements with pharma and biotech partners and broadening our benchmarked model coverage.
Certifications & Accreditations
We are committed to the highest standards of quality, security, and compliance.
We follow strict data-handling and reproducibility standards, and we share our compliance and evaluation documentation directly with partners during pilot scoping.
Meet Our Team
Our team's strength lies in its expertise across artificial intelligence and biomedical science.
Pratap Singha
Founder & CTO
Pratap Singha leads PathoscribeAI's technology strategy and product architecture, with a strong focus on scalable AI systems for drug discovery and biomedical data intelligence. He drives platform engineering, model integration, and technical execution across the company's core solutions.
AI
Python
ML
Computational Biology
Ashutosh Routh
Co-founder & CEO
Ashutosh Routh shapes the company's strategic direction, partnerships, and growth roadmap. He works at the intersection of business development and product vision, ensuring PathoscribeAI delivers commercially relevant AI solutions for healthcare, pharma, and research organizations.
Business Development
Strategy
Product Vision
Soumya Ranjan Acharya
Co-founder & COO
Soumya Ranjan Acharya oversees operations, delivery planning, and cross-functional coordination across the organization. He focuses on execution excellence, process design, and translating strategic goals into reliable day-to-day outcomes.
Operations
Process Design
Project Management
Samarth Vaishnav
CMO
Samarth Vaishnav leads PathoscribeAI's market positioning, brand communication, and growth marketing initiatives. He focuses on building a professional market presence, communicating product value clearly, and expanding the company's reach across high-intent industry audiences.
Marketing
Brand Communication
Growth Marketing